Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RLMD

RELMADA THERAPEUTICS, INC.

CIK 0001553643 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$4.63
↓ 0.01 (-0.22%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$493.88M
P/E Ratio
-7.98
EPS
-1.45
Dividend Yield
Not covered
52W Position
55%
Beta
1.38

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.39
P/S
Not covered
EV/Revenue
Not covered
ROE
-30.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 55%
$0.59$8.00

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$57.39M
Total Assets
$94.00M
Free Cash Flow
–

Recent news